COVID-19 Adenoviral Vector Vaccination Elicits a Robust Memory B Cell Response with the Capacity to Recognize Omicron BA.2 and BA.5 Variants

Following the COVID-19 pandemic, novel vaccines have successfully reduced severe disease and death. Despite eliciting lower antibody responses, adenoviral vector vaccines are nearly as effective as mRNA vaccines. Therefore, protection against severe disease may be mediated by immune memory cells. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Fryer, Holly A., Hartley, Gemma E., Edwards, Emily S. J., Varese, Nirupama, Boo, Irene, Bornheimer, Scott J., Hogarth, P. Mark, Drummer, Heidi E., O’Hehir, Robyn E., van Zelm, Menno C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10499924/
https://www.ncbi.nlm.nih.gov/pubmed/37322095
http://dx.doi.org/10.1007/s10875-023-01527-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10499924/
https://www.ncbi.nlm.nih.gov/pubmed/37322095
http://dx.doi.org/10.1007/s10875-023-01527-2

Ejemplares similares